Primary Jurisdiction Doctrine Bars Supplement Lawsuit, Ga. Appellate Court Affirms



DOCUMENTS
  • Opinion


ATLANTA — A Georgia appellate court has affirmed that a lawsuit targeting a dietary supplement containing methylsynephrine is barred under the doctrine of primary jurisdiction because the Food and Drug Administration has not taken final agency action to determine whether the product is safe.

In a June 24 opinion, the Georgia Court of Appeals explained that the action involves questions concerning “the evaluation of conflicting scientific evidence in the complex areas of product and ingredient classification and health and safety” that are best left for the FDA to decide.

Shawn Smith sued Hi-Tech Pharmaceuticals Inc. in the Gwinnett County (Ga.) …






UPCOMING CONFERENCES




HarrisMartin's Mass Tort Settlements Conference - Sponsored by Milestone

June 27, 2024 - Buffalo, NY
The Richardson Hotel Buffalo

MORE DETAILS



HarrisMartin's MDL Conference: Video Game Addiction and the Latest Mass Tort Updates

May 29, 2024 - Salt Lake City, UT
The Grand America Hotel

MORE DETAILS